---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-196966"
form_type: "8-K"
ticker: "ALGS"
cik: "0001799448"
company_name: "Aligos Therapeutics, Inc."
filed_at: "2024-08-08T23:59:59+00:00"
generated_at: "2026-05-31T11:08:02.899774+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Aligos appoints Heather Preston and Margarita Chavez to Board

## Summary
- Board expanded to seven directors; Preston and Chavez appointed as Class II directors through 2025 annual meeting.
- Dr. Preston will chair the Nominating Committee; Ms. Chavez joins the Audit Committee.
- Each receives $40k annual retainer (prorated) and an initial option for 120,000 shares.
- Chavez gets additional $7,500/yr for Audit; Preston gets $8,000/yr for Nominating chair (both prorated).
- Both entered standard indemnification agreements; no material relationships requiring disclosure.

## SEC filing metadata
- accession: 0001193125-24-196966
- form_type: 8-K
- ticker: ALGS
- cik: 0001799448
- company_name: Aligos Therapeutics, Inc.
- filed_at: 2024-08-08T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799448/000119312524196966/0001193125-24-196966-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799448/000119312524196966/d875950d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-196966
- JSON: https://secwatch.observer/filing/0001193125-24-196966.json
- Plain text: https://secwatch.observer/filing/0001193125-24-196966.txt

## Key facts
- Executive change
  Heather Preston was appointed as Director at Aligos Therapeutics, Inc..
  - Action: appointed
  - Role: Director
  source text: appointed Heather Preston, M.D. and Margarita Chavez, J.D., to the Board to fill the newly created directorships
  evidence_url: https://www.sec.gov/Archives/edgar/data/1799448/000119312524196966/0001193125-24-196966-index.htm
- Executive change
  Margarita Chavez was appointed as Director at Aligos Therapeutics, Inc..
  - Action: appointed
  - Role: Director
  source text: appointed Heather Preston, M.D. and Margarita Chavez, J.D., to the Board to fill the newly created directorships
  evidence_url: https://www.sec.gov/Archives/edgar/data/1799448/000119312524196966/0001193125-24-196966-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.